In a recent study, SFX was found to be effective in reducing the level of circulating exosomes carrying PD-L1 in CT26 tumor-bearing mice, which reinvigorated the function of CD8 cytotoxic T cells and enhanced the efficacy of anti-PD-1 immunotherapy111. The gene discussed is CD274; the disease is neoplasm.